FDA Advisory Committee Changes: The FDA will eliminate pharmaceutical company employees from its advisory committees, aiming to reduce industry influence and elevate the role of patients and caregivers.
- Commissioner Marty Makary announced this to ensure independent scientific evaluations.
- Pharma reps can attend meetings like public attendees but won’t have an influential role.
- This change seeks to enhance public trust and committee operations.
- Exceptions may occur for special expertise or statutory requirements.
- The FDA Modernization Act of 1997 mandates non-voting industry presence on certain panels.
Tags #International, #Government, #Security
Want to read more about this ? One of the original source articles from a trusted news source (not legacy media) is here:
